Duijnisveld et al. have published an interesting study on the regenerative potential of muscle satellite cells in chronic inflammation in this journal [1]. They showed that muscle stem cell populations obtained from M. vastus medialis of patients with rheumatoid arthritis (RA) and osteoarthritis (OA) exhibited similar myogenic purity, viability, growth speed, differentiation, and maximum proliferative capacity. Based on these findings in vitro, the authors hypothesized that circulating inflammatory factors in RA negatively influence the regenerative potential of satellite cells and muscle strength in vivo. We aimed to verify whether these results obtained from vastus medialis muscles also apply to a muscle typically involved in the disease process of RA, namely M. interosseus dorsalis manus 1.
For this purpose, we obtained intraoperative muscle biopsies from the M. interosseus dorsalis manus 1 of five RA (57.2 ± 11.1 years old) and four OA (60.7 ± 12.1 years old) patients and tested whether satellite cell numbers, myofiber sizes, and proportions were different between RA and OA patients. There was no difference in muscle fiber type distribution between RA and OA patients (Table 1). Myofiber cross-sectional area (CSA), myonuclear domains, the number of Pax7+ cells, and the number of proinflammatory macrophages (CD68+) were not different between RA and OA patients. There was a tendency for increased myonuclear number in myosin heavy chain (MyHC)-1 fibers in RA patients compared with OA patients, while there was no difference in myonuclear number in MyHC-2 fibers between the groups. MyHC-2 fiber CSAs in M. interosseus dorsalis manus 1 were significantly larger than MyHC-1 CSAs in RA and OA patients (Table 1).
Table 1
M. interosseus dorsalis manus 1 characteristics in rheumatoid arthritis and osteoarthritis patients
Rheumatoid arthritis (n = 5) | Osteoarthritis (n = 4) | |
|---|---|---|
MyHC-1 (%) | 74.4 ± 15.6 | 73.3 ± 19.8 |
MyHC-2A (%) | 23.8 ± 13.6 | 23.6 ± 20.8 |
MyHC-2X (%) | 1.8 ± 2.3 | 3.1 ± 3.2 |
CSA MyHC-1 (μm2) | 2534 ± 714 | 1906 ± 773 |
CSA MyHC-2 (μm2) | 4263 ± 1752* | 3177 ± 1201* |
MN MyHC-1 | 2.31 ± 0.47 | 1.95 ± 0.31 |
MN MyHC-2 | 3.06 ± 0.75 | 2.06 ± 0.66# |
MND MyHC-1 (μm2) | 1240 ± 389 | 1093 ± 323 |
MND MyHC-2 (μm2) | 1523 ± 382 | 1354 ± 550 |
Pax7+ MyHC-1 | 0.038 ± 0.025 | 0.020 ± 0.008 |
Pax7+ MyHC-2 | 0.049 ± 0.075 | 0.028 ± 0.025 |
CD86+ MyHC-1 | 0.036 ± 0.019 | 0.034 ± 0.020 |
CD86+ MyHC-2 | 0.055 ± 0.025 | 0.038 ± 0.026 |
Anzeige
Our results point towards similar muscle characteristics between RA and OA patients in the highly affected M. interosseus dorsalis manus 1. Moreover, we found that most values for RA patients seemed to be higher when compared with OA in this preliminary dataset. Notably, there was a tendency for increased myonuclear number in MyHC-1 fibers in RA patients. Our results from a severely affected skeletal area are in line with previous studies investigating other skeletal sites. In M. vastus medialis, MyHC-2 CSAs were significantly larger than MyHC-1 CSAs in RA patients [2] and no significant differences in satellite cell numbers between RA and OA patients were present [3]. Based on our results from a small patient sample, the hypothesis that chronic systematic inflammation negatively influences the regenerative potential of satellite cells and myonuclei number cannot be confirmed, but it warrants further investigation.
Acknowledgements
Not applicable.
Funding
Not applicable.
Availability of data and materials
The datasets of the current study are available from the corresponding author on reasonable request.
Anzeige
Ethics approval and consent to participate
Written informed consent was obtained from all participants and the study was conducted according to the bylaws of the institution.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.